Fertility preservation

San Diego Fertility Center, an Ivy Fertility Clinic, Hires Dr. Valerie Flores

Retrieved on: 
Wednesday, February 21, 2024
Research, Women, Baby, Maternity, Practice Management, Family, Biotechnology, General Health, Consumer, Health, Science, Fertility preservation, MD, NIH, Physician, Pain, Endometriosis, University of Southern California, Yale University, University, SDFC, PCOS, Patient, Uterus, Brown, Infertility, Medical device

Ivy Fertility, a collaborative network of globally-renowned fertility clinics, has welcomed Valerie Flores, MD to its team of physicians at San Diego Fertility Center (SDFC).

Key Points: 
  • Ivy Fertility, a collaborative network of globally-renowned fertility clinics, has welcomed Valerie Flores, MD to its team of physicians at San Diego Fertility Center (SDFC).
  • “We are thrilled that Dr. Flores will be contributing her talents to our physician team,” said Sandy Chuan, MD, medical director at San Diego Fertility Center.
  • She comes to San Diego Fertility Center from Reproductive Partners Fertility Center in San Diego, is an Assistant Professor Adjunct at Yale University’s School of Medicine.
  • “I admire San Diego Fertility Center and Ivy Fertility for leading our industry by putting compassion and collaboration first,” said Dr. Flores.

Castle Connolly Names 40 Physicians within The Prelude Network® as 2024 Top Doctors

Retrieved on: 
Tuesday, February 13, 2024
Fertility preservation, IUI, Education, Reproductive medicine, Physician, Dream, IVF, Parent, Pleasure, Castle Connolly Medical, PGT, NYU, Faculty, Prelude, Vitrification, Artificial insemination, NYU Langone Health, Patient, Genetic testing, Nursing

HOUSTON, Feb. 13, 2024 /PRNewswire/ -- The Prelude Network® (Prelude), the largest and fastest-growing network of fertility providers in North America, today celebrates 40 of its physicians across 14 clinics within its expansive network who are named a 2024 Top Doctor by Castle Connolly.

Key Points: 
  • The recognition methodology has been vetted and endorsed by the Castle Connolly Medical Advisory Board .
  • Prelude specialists include innovators in fertility care who have pioneered some of today's most advanced reproductive technologies, including vitrification, fertility preservation, and preimplantation genetic testing (PGT).
  • Dr. Jamie Grifo , Program Director at NYU Langone Fertility and Chief Executive Physician of Inception, was named a 2024 Castle Connolly Top Doctor for the 25th year in a row.
  • "Inception Fertility extends its heartfelt congratulations to our incredible physicians who are so deserving of the Top Doctor recognition," says TJ Farnsworth, Founder and CEO of Inception Fertility.

HRC Fertility Center Adds Dr. Irene Woo to Its Roster of Prominent Doctors

Retrieved on: 
Tuesday, February 13, 2024
Women, Hospitals, Baby, Maternity, Genetics, LGBTQ+, Practice Management, Health, Consumer, General Health, Gynaecology, Fertility preservation, MD, Reproductive technology, Fertility, IVF, HRC, Empathy, FACOG, Medicine, Patient, Journal, Patient safety, Environment, Diagnosis, Research, Book, Nursing

HRC Fertility Center (HRC), one of the largest providers of advanced fertility treatments based in Southern California, today announced the addition of Irene Woo, MD, FACOG , to its team of award-winning physicians.

Key Points: 
  • HRC Fertility Center (HRC), one of the largest providers of advanced fertility treatments based in Southern California, today announced the addition of Irene Woo, MD, FACOG , to its team of award-winning physicians.
  • Woo, an esteemed and compassionate medical professional holding dual board certifications in Obstetrics and Gynecology and Reproductive Endocrinology and Infertility, has joined the center’s Encino office.
  • “I became part of HRC due to its esteemed reputation and commitment to exemplary medical practices,” said Dr.
  • Woo.

Florida Reproductive Specialists by IVF FLORIDA Introduces World-Class Fertility Care to North Florida

Retrieved on: 
Wednesday, January 17, 2024
Patient, Fertility, Gynaecology, IVF, Partnership, Cancer, Fertilisation, Suite, Fertility preservation, Birth control

Florida Reproductive Specialists is dedicated to delivering state-of-the-art technology, inclusive fertility care, and compassionate medical guidance.

Key Points: 
  • Florida Reproductive Specialists is dedicated to delivering state-of-the-art technology, inclusive fertility care, and compassionate medical guidance.
  • Florida Reproductive Specialists is a partner with IVF FLORIDA Reproductive Associates , a reputable provider of fertility treatments in South Florida since 1986.
  • With multiple locations throughout Florida, both Florida Reproductive Specialists and IVF FLORIDA Reproductive Associates deliver comprehensive and empathetic care to individuals and couples pursuing family-building solutions.
  • Florida Reproductive Specialists and IVF FLORIDA are proud partner practices of US Fertility , the largest physician-owned and physician-led partnership of top-tier fertility practices nationally.

Groundbreaking Early-Age Onset Colorectal Cancer Think Tank Aims to Transform Colorectal Cancer Outcomes

Retrieved on: 
Wednesday, November 29, 2023
Shock, Fatality, CRC, Colorectal cancer, Risk, Vanderbilt-Ingram Cancer Center, Research, Hope, Large intestine, Colonoscopy, Fertility preservation, EAO, Fertility, Cancer, Body image, Patient, Young adult

On December 1, 2023, co-hosted with Vanderbilt-Ingram Cancer Center, Fight CRC will leverage innovation and collaboration by convening leading researchers, medical professionals, and emerging scientists at the Early-age Onset Colorectal Cancer (EAO CRC) Think Tank, with a singular objective: to save young lives from colorectal cancer.

Key Points: 
  • On December 1, 2023, co-hosted with Vanderbilt-Ingram Cancer Center, Fight CRC will leverage innovation and collaboration by convening leading researchers, medical professionals, and emerging scientists at the Early-age Onset Colorectal Cancer (EAO CRC) Think Tank, with a singular objective: to save young lives from colorectal cancer.
  • The EAO CRC Think Tank is an extension of Fight CRC's Path to a Cure initiative , aiming to mobilize colorectal cancer champions nationwide, engage them in the scientific research process, and advocate for colorectal cancer research funding while effectively communicating research findings to the public.
  • In response, Fight CRC has taken proactive measures by establishing the EAO CRC Think Tank and forming strategic partnerships with leading experts in the colorectal cancer medical community.
  • Fight CRC President Anjee Davis states, " We are thrilled to be convening the Early-age Onset Colorectal Cancer Think Tank, uniting the foremost experts in colorectal cancer research.

Maya Barsky, MD, MSCI Joins the Center for Advanced Reproductive Services as a Lead Physician

Retrieved on: 
Tuesday, December 12, 2023
REI, Assistant, Brown University, Research, Fertility, Baylor University, University, Patient, Pulsus Group, Baylor College of Medicine, American College, ACOG, ASRM, PCOS, Reproductive medicine, Fertility preservation, Society, Meigs's syndrome, Ovarian reserve, Birth control, Infertility, Gynaecology

FARMINGTON, Conn., Dec. 12, 2023 /PRNewswire/ -- The Center for Advanced Reproductive Services, one of the leading family building programs in the country, announced Dr. Maya Barsky, reproductive endocrinologist, has joined as Lead Physician and Assistant Professor in the Department of Ob/Gyn at UConn School of Medicine.

Key Points: 
  • FARMINGTON, Conn., Dec. 12, 2023 /PRNewswire/ -- The Center for Advanced Reproductive Services, one of the leading family building programs in the country, announced Dr. Maya Barsky, reproductive endocrinologist, has joined as Lead Physician and Assistant Professor in the Department of Ob/Gyn at UConn School of Medicine.
  • "I am very fortunate to be a part of such a respected and successful program as the Center for Advanced Reproductive Services."
  • Dr. Barsky is available to connect with patients via telehealth appointments effective immediately, with in-person appointments beginning in January 2024.
  • Prior to joining The Center for Advanced Reproductive Services, she was part of a private fertility practice in Austin, TX for several years.

Amir Mor, Ph.D., M.D., Joins Fertility Centers of New England

Retrieved on: 
Tuesday, December 5, 2023
Gynaecology, Patient, IVF, Reproductive medicine, Fertility preservation, Health, Birth control, Infertility, Obstetrics

READING, Mass., Dec. 5, 2023 /PRNewswire/ -- The Fertility Centers of New England is pleased to welcome Amir Mor, Ph.D., M.D., as its newest infertility specialist.

Key Points: 
  • READING, Mass., Dec. 5, 2023 /PRNewswire/ -- The Fertility Centers of New England is pleased to welcome Amir Mor, Ph.D., M.D., as its newest infertility specialist.
  • Dr. Mor is board-certified in Obstetrics and Gynecology, and board-eligible in Reproductive Endocrinology and Infertility.
  • Dr. Mor joins Fertility Centers of New England from New York City where he was the founder and director of the Mor Fertility Center.
  • "Dr. Mor's dedication to patient care is well known in the New York City area, and we are delighted to have him join our team," said Fertility Centers of New England President Joseph A. Hill, M.D.

HSS Presents New Reproductive Health Research at the ACR Convergence 2023

Retrieved on: 
Tuesday, November 14, 2023
Knowledge, Woman, Cervical cancer, Contraindication, Patient, Rheumatoid arthritis, Documentation, SLE, Infertility, Diagnosis, Rheumatology, Rheumatism, Fertility, Prevalence, Menopause, Vaccination, Cryopreservation, Flare, DSM-IV codes, Birth, Connective tissue, Hospital for Special Surgery, Doctor of Public Health, Female, Fetus, Smoking, Senior counsel, RD, SAN, Menstrual cycle, Weill Cornell Medicine, Immunosuppression, Risk, History, Hysterectomy, Inflammatory arthritis, Lupus, HSS, PAP, Fertilisation, OOC, Research, Human papillomavirus infection, Ageing, Scleroderma, Systemic scleroderma, Vaccine, American College, American College of Rheumatology, COVID-19, Fertility preservation, MPH, ACR, HPV, Hospital, Birth control, Nursing, Food delivery, MD

Additional research is planned to assess whether demographics, lifestyle and medical conditions may influence this potential association.

Key Points: 
  • Additional research is planned to assess whether demographics, lifestyle and medical conditions may influence this potential association.
  • This study surveyed women of reproductive age with systemic rheumatic disease about their use of contraceptives.
  • Data were collected on 249 women with reproductive capacity, including 147 with inflammatory arthritis and 102 with lupus-like disorders.
  • This study used data from the electronic health record of patients diagnosed with a rheumatic disease in adolescence, seen at HSS, to look at factors associated with HPV vaccination.

Kindbody Ranked No. 30 Fastest-Growing Company in North America on the 2023 Deloitte Technology Fast 500™

Retrieved on: 
Wednesday, November 8, 2023
Fertility, Female, Digital, Business Leaders for Michigan, Genetic testing, CNBC, Physician, Fertility clinic, Marital status, Male, Deloitte Technology Fast 500, Gender identity, IVF, Growth, Partnership, Telecommunications, Patient, Fertility preservation, Mental health, Nursing

NEW YORK, Nov. 8, 2023 /PRNewswire/ -- Kindbody, the leading national fertility clinic network and global family-building benefits provider for employers, today announced it was ranked No. 30 on the Deloitte Technology Fast 500™, which recognizes the fastest growing and most innovative technology companies in North America. Kindbody grew nearly 6,000% during the period of 2019 to 2022 due to the growing demand for fertility and family-building care from employers and patients nationwide.

Key Points: 
  • 30 on the Deloitte Technology Fast 500 ™, which recognizes the fastest growing and most innovative technology companies in North America.
  • "We are thrilled to receive this honor from Deloitte and be recognized alongside so many of the world's most innovative companies," said Scott Bruckner, Chief Financial Officer of Kindbody.
  • Placement on the Deloitte Technology Fast 500 is the latest in the string of growth, innovation, and workplace-related recognition Kindbody has garnered in 2023.
  • Employers who wish to learn more about how Kindbody delivers the best patient experience and outcomes while reducing healthcare costs can contact [email protected] .

Dynami Funds New Groundbreaking Research for Lobular Breast Cancer

Retrieved on: 
Wednesday, November 1, 2023
Dean (education), Karmanos Cancer Institute, Biomarker, Leigh, Doctor of Philosophy, Disease, Risk, Partnership, DRS, University of Michigan, UPMC, Fertility preservation, Hope, Physician, Hereditary lobular breast cancer, Impact, University of Pittsburgh Medical Center, IVF, Breast cancer, University, Morávek, Cancer, Patient, Biomedical engineering, ILC, University of Colorado, History, MD, Work, Woman, University of Colorado School of Medicine, Black, Multimedia, Recurrence, Personalized medicine, United States and Canadian Academy of Pathology, Medical device, Vaccine, Medical imaging, Birth control, Pharmaceutical industry, Research, Pathology, Pharmacology, Dynamy

DETROIT, Nov. 1, 2023 /PRNewswire/ -- The Dynami Foundation has funded groundbreaking new research and support for lobular breast cancer through their partnership with University of Michigan Health. Recently released University of Michigan Health Impact Report outlines the progress and work made possible by the Dynami Foundation's initiatives that are focused on transforming the future of invasive lobular breast cancer (ILC) through the funding of research.

Key Points: 
  • DETROIT, Nov. 1, 2023 /PRNewswire/ -- The Dynami Foundation has funded groundbreaking new research and support for lobular breast cancer through their partnership with University of Michigan Health.
  • From groundbreaking new research on circulating cells to a dual-institution effort to combat cancer, Dynami and University of Michigan have partnered to drive progress.
  • A patient-centered decision-making process by understanding goals of lobular breast cancer patients for an elevated, personalized breast reconstruction experience led by Dr. Paige Myers.
  • Dynami has funded over 12 research projects and will continue to fight for advancement for lobular breast cancer just like the incredible work and impact that we've made here."